Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies

Archives of Internal Medicine

Volumn 164, Issue 19, 2004, Pages 2147-2155

  Levitan, Emily B ^a,b   Song, Yiqing ^a,b   Ford, Earl S ^c   Liu, Simin ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

AGE DISTRIBUTION; ARTICLE; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPARATIVE STUDY; DATA ANALYSIS; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; PATIENT INFORMATION; PRIORITY JOURNAL; PUBLICATION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL;

ADULT; AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 6944253559     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.19.2147     Document Type: Article

References (62)

1. Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality: the San Antonio Heart Study. Diabetes Care. 1998;21:1167-1172.
2. Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia. 1996;39:1577-1583.
3. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes. 1994;43:960-967.
4. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med. 2003;348:2294-2303.
5. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003;26(suppl):S5-S20.
6. Alberti KGMM, Aschner P, Assal JP, et al. Definition. In: Diagnosis, and Classification of Diabetes Mellitus and its Complications: Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 1999.
7. Perry RC, Baron AD. Impaired glucose tolerance: why is it not a disease? Diabetes Care. 1999;22:883-885.
8. Gerstein HC, Yusuf S. Dysglycaemia and risk of cardiovascular disease. Lancet. 1996;347:949-950.
9. International Collaborative Group. Asymptomatic hyperglycemia and coronary heart disease: a series of papers by the International Collaborative Group, based on studies in fifteen populations. J Chronic Dis. 1979;32:681-837.
10. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999;22:233-240.
11. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW; Framingham Offspring Study. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care. 2002;25:1845-1850.
12. Wingard DL, Barrett-Connor E. Heart disease and diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, eds. Diabetes in America. 2nd ed. Bethesda, Md: National Institutes of Health, National Institute of Diabetes & Digestive and Kidney Diseases; 1995:429-448.
13. Clarke R. Review: glucose levels are associated with cardiovascular risk in persons without diabetes mellitus. ACP J Club. 1999;131:23.
14. Goldman L, Bennett JC. Cecil Textbook of Medicine. 21st ed. Philadelphia, Pa: WB Saunders Co; 2000.
15. Thompson SG. Why and how sources of heterogeneity should be investigated. In: Egger M, Smith GD, Altman DG, eds. Systematic Reviews in Health Care: Meta-analysis in Context. 2nd ed. London, England: BMJ Publishing Group; 2001.
16. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289:579-588.
17. Vaccaro O, Ruth KJ, Stamler J. Relationship of postload plasma glucose to mortality with 19-yr follow-up: comparison of one versus two plasma glucose measurements in the Chicago Peoples Gas Company Study. Diabetes Care. 1992; 15:1328-1334.
18. Fujishima M, Kiyohara Y, Kato I, et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: the Hisayama Study. Diabetes. 1996;45:S14-S16.
19. Park S, Barrett-Connor E, Wingard DL, Shan J, Edelstein S. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes: the Rancho Bernardo Study. Diabetes Care. 1996;19:450-456.
20. Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men: the Chicago Heart Association Detection Project in Industry Study. Diabetes Care. 1997;20:163-169.
21. Balkau B, Shipley M, Jarrett RJ, et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care. 1998;21:360-367.
22. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care. 1999;22:920-924.
23. Rodriguez BL, Lau N, Burchfiel CM, et al. Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care. 1999;22:1262-1265.
24. DECODE Study Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001;161:397-405.
25. Saydah SH, Miret M, Sung J, Varas C, Gause D, Brancati FL. Postchallenge hyperglycemia and mortality in a national sample of US adults. Diabetes Care. 2001;24:1397-1402.
26. Smith NL, Barzilay JI, Shaffer D, et al. Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med. 2002;162:209-216.
27. Lapidus L, Bengtsson C, Blohme G, Lindquist O, Nystrom E. Blood glucose, glucose tolerance and manifest diabetes in relation to cardiovascular disease and death in women: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand. 1985;218:455-462.
28. Ohlson LO, Svardsudd K, Welin L, et al. Fasting blood glucose and risk of coronary heart disease, stroke, and all-cause mortality: a 17-year follow-up study of men born in 1913. Diabet Med. 1986;3:33-37.
29. Yarnell JW, Pickering JE, Elwood PC, et al. Does non-diabetic hyperglycemia predict future IHD? evidence from the Caerphilly and Speedwell studies. J Clin Epidemiol. 1994;47:383-388.
30. Casiglia E, Pauletto P, Mazza A, et al. Impaired glucose tolerance and its covariates among 2079 non-diabetic elderly subjects: ten-year mortality and morbidity in the CASTEL Study (CArdiovascular STudy in the ELderly). Acta Diabetol. 1996;33:284-290.
31. Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 1997;20:935-942.
32. Cremer P, Nagel D, Mann H, et al. Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS), I: risk factors for myocardial infarction in a cohort of 5790 men. Atherosclerosis. 1997;129:221-230.
33. Bjornholt JV, Erikssen G, Aaser E, et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death: results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care. 1999;22:45-49.
34. Simons LA, Friedlander Y, McCallum J, Simons J. Fasting plasma glucose in non-diabetic elderly women predicts increased all-causes mortality and coronary heart disease risk. Aust N Z J Med. 2000;30:41-47.
35. Henry P, Thomas F, Benetos A, Guize L. Impaired fasting glucose, blood pressure and cardiovascular disease mortality. Hypertension. 2002;40:458-463.
36. Haheim LL, Holme I, Hjermann I, Leren P. Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects: 18-year follow-up of the Oslo Study. Stroke. 1995;26:774-777.
37. Hart CL, Hole DJ, Smith GD. Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley Study in Scotland. Stroke. 1999;30:1999-2007.
38. Wannamethee SG, Perry IJ, Shaper AG. Nonfasting serum glucose and insulin concentrations and the risk of stroke. Stroke. 1999;30:1780-1786.
39. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care. 2002;25:1790-1794.
40. de Vegt F, Dekker JM, Ruhe HG, et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia. 1999;42:926-931.
41. Da Silva A, Widmer LK, Ziegler HW, Nissen C, Schweizer W. The Basle Longitudinal Study: report on the relation of initial glucose level to baseline ECG abnormalities, peripheral artery disease, and subsequent mortality. J Chronic Dis. 1979;32:797-803.
42. Ducimetiere P, Eschwege E, Richard J, Claude J, Elgrishi I. Relationship of glucose tolerance to prevalence of ECG abnormalities and to annual mortality from cardiovascular disease: results of the Paris Prospective Study. J Chronic Dis. 1979;32:759-766.
43. Fuller JH, McCartney P, Jarrett RJ, et al. Hyperglycaemia and coronary heart disease: the Whitehall Study. J Chronic Dis. 1979;32:721-728.
44. Reunanen A, Pyorala K, Aromaa A, Maatela J, Knekt P. Glucose tolerance and coronary heart disease in middle-aged Finnish men: Social Insurance Institution's Coronary Heart Disease Study. J Chronic Dis. 1979;32:747-758.
45. Stamler R, Stamler J, Lindberg HA, et al. Asymptomatic hyperglycemic and coronary heart disease in middle-aged men in two employed populations in Chicago. J Chronic Dis. 1979;32:805-815.
46. Stenhouse NS, Murphy BP, Welborn TA. Busselton Population Study: risk associated with asymptomatic hyperglycemic. J Chronic Dis. 1979;32:693-698.
47. Orencia AJ, Daviglus ML, Dyer AR, Walsh M, Greenland P, Stamler J. One-hour postload plasma glucose and risks of fatal coronary heart disease and stroke among nondiabetic men and women: the Chicago Heart Association Detection Project in Industry (CHA) Study. J Clin Epidemiol. 1997;50:1369-1376.
48. Agewall S. Should we do an oral glucose tolerance test in hypertensive men with normal fasting blood-glucose? J Hum Hypertens. 2001;15:71-74.
49. Stern MP, Fatehi P, Williams K, Haffner SM. Predicting future cardiovascular disease: do we need the oral glucose tolerance test? Diabetes Care. 2002;25:1851-1856.
50. Schroll M, Hagerup L. Relationship of fasting blood glucose to prevalence of ECG abnormalities and 10 yr risk of mortality from cardiovascular diseases in men born in 1914: from the Glostrup Population Studies. J Chronic Dis. 1979;32:699-707.
51. Barrett-Connor E, Wingard DL, Criqui MH, Suarez L. Is borderline fasting hyperglycemia a risk factor for cardiovascular death? J Chronic Dis. 1984;37:773-779.
52. Tomas-Abadal L, Varas-Lorenzo C, Bernades-Bernat E, Balaguer-Vintro I. Coronary risk factors and a 20-year incidence of coronary heart disease and mortality in a Mediterranean industrial population: the Manresa Study, Spain. Eur Heart J. 1994;15:1028-1036.
53. Wilson PW, Cupples LA, Kannel WB. Is hyperglycemia associated with cardiovascular disease? the Framingham Study. Am Heart J. 1991;121:586-590.
54. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(suppl 1):S5-S10.
55. Kanaya AM, Grady D, Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med. 2002;162:1737-1745.
56. DECODE Study Group. Gender differences in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia. 2003;46:608-617.
57. Gerich JE. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med. 2003;163:1306-1316.
58. King GL, Wakasaki H. Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes. Diabetes Care. 1999;22(suppl 3):C31-C37.
59. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48:937-942.
60. Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ. 2001;322:15-18.
61. Chiasson J-L, Josse RG, Gomis R, et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM Trial. JAMA. 2003;290:486-494.
62. Brand-Miller J, Petocz P, Hayne S, Colagiuri S. Low-glycemic index diets in the management of diabetes. Diabetes Care. 2003;26:2261-2267.